Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.21.2
Summary of Significant Accounting Policies (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Nov. 30, 2019
Warrants, exercise price $ 3.92   $ 3.92    
Potentially dilutive shares outstanding (in shares) 1,242,357   1,242,357    
Pre Funded Warrants          
Warrants issued to purchase shares of common stock 253,828 568,093 253,828 568,093  
Warrants, exercise price         $ 0.001
Excess warrant shares held in abeyance   803,300   803,300